2016.a. publikatsioonid

Kokku publikatsioone: 210

Artiklid rahvusvahelistes ajakirjades
1Arnardottir ESS., Verbraecken J., Goncalves M., Gjerstad MD., Grote L., Puertas Cuesta FJ., Mihaicuta S., McNicholas WT., Parrino L., The National Representatives as Study Collaborators
Autorite grupp:Sõõru E.
Variability in recording and scoring of respiratory events during sleep in Europe: a need for uniform standards
PUBMED
Journal of Sleep Research: 25 (2), 144-157, 2016
2Arund J., Luman M., Uhlin F., Tanner R., Fridolin I.
Is fluorescence valid to monitor removal of protein bound uremic solutes in dialysis?
PUBMED
PLoS ONE: 11 (5), Artikkel nr e0156541, 2016
3Asser A., Kõks S., Snellman A., Haaparanta-Solin M., Arponen E., Grönroos T., Nairismägi J., Bergquist J., Soomets U., Piip P., Eltermaa M., Sauk M., Lindmäe H., Rinne JO., Taba P.
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese
PUBMED
Brain Research: 1652, 97-102, 2016
4Bandelow B., Baldwin DS., Abelli M., Altamura AC., Dell'Osso B., Domschke K., Fineberg NA., Grünblatt E., Jarema M., Maron E., Nutt DJ., Pini S., Vaghi MM., Wichniak A., Zai G., Riederer P.
Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics
PUBMED
World Journal of Biological Psychiatry: 17 (5), 321-365, 2016
5Braschinsky M., Raidvee A., Sabre L., Zmatšinskaja N., Zukovskaja O., Karask A., Saar B., Rakitin A.
3D Cinema and Headache: The First Evidential Relation and Analysis of Involved Factors
PUBMED
Frontiers in Neurology: 7, Artikkel nr 30, 2016
6Breton J., Legrand R., Akkermann K., Järv A., Harro J., Dechelotte P., Fetissov S.
Elevated plasma concentrations of bacterial ClpB protein in patients with eating disorders
PUBMED
International Journal of Eating Disorders: 49 (8), 805-808, 2016
7Candemir E., Kollert L., Weissflog L., Geis M., Müller A., Post AM., O'Leary A., Harro J., Reif A., Freudenberg F.
Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology
PUBMED
European Neuropsychopharmacology: 26 (4), 741-755, 2016
8Casar B., do Carmo Lopes M., Drljevic A., Gerškevitš E., Pesznyak C.
Medical physics in Europe following recommendations of the International Atomic Energy Agency
PUBMED
Radiology and Oncology: 50 (1), 64-72, 2016
9Catapano AL., Graham I., De Backer G., Wiklund O., Chapman MJ., Drexel H., Hoes AW., Jennings CS., Landmesser U., Pedersen TR., Reiner Ž., Riccardi G., Taskinen MR., Tokgozoglu L., Verschuren WMM., Vlachopoulos C., Wood DA., Zamorano JL., Cooney MT., European Society of Cardiology (ESC) Scientific Document Group
Autorite grupp:Viigimaa M.
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
PUBMED
European Heart Journal: 37 (39), 2999-3058, 2016
10Cegielski JP., Kurbatova E., van der Walt M., Brand J., Ershova J., Tupasi TE., Caoili JC., Dalton T., Contreras C., Yagui M., Bayona J., Kvasnovsky C., Leimane V., Kuksa L., Chen MP., Via LE., Hwang SH., Wolfgang M., Volchenkov G., Somova T., Smith SE., Akksilp S., Wattanaamornkiet W., Kim HJ., Kim CK., Kazennyy B., Khorosheva T., Kliiman K., Viiklepp P., Jou R., Huang AS., Vasilyeva I., Demikhova O., Global Preserving Effective TB Treatment Study (PETTS) Investigators
Autorite grupp:Danilovitš M., Kummik T., Levina K.
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance
PUBMED
Clinical Infectious Diseases: 62 (4), 418-430, 2016
11Cohen AT., Harrington RA., Goldhaber SZ., Hull RD., Wiens BL., Gold A., Hernandez AF., Gibson CM., Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) Investigators
Autorite grupp:Lember M., Marandi T., Uuetoa T.
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
PUBMED
New England Journal of Medicine: 375 (6), 534-544, 2016
12De Kort W., Mayr W., Jungbauer C., Vuk T., Kullaste R., Seifried E., Grazzini G., de Wit J., Follea G.
Blood donor selection in European Union directives: room for improvement
PUBMED
Blood Transfusion: 14 (2), 101-108, 2016
13Ferrari R., Aguiar C., Alegria E., Bonadonna RC., Cosentino F., Elisaf M., Farnier M., Ferrieres J., Filardi PP., Hancu N., Kayikcioglu M., Silva AME., Millan J., Reiner Ž., Tokgozoglu L., Valensi P., Viigimaa M., Vrablik M., Zambon A., Zamorano JL., Catapano AL.
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
European Heart Journal Supplements: 18 (C), C2-C12, 2016
14Fitchett D., Zinman B., Wanner C., Lachin JM., Hantel S., Salsali A., Johansen OE., Woerle HJ., Broedl UC., Inzucchi SE., EMPA-REG OUTCOME® trial investigators
Autorite grupp:Lubi M., Marandi T.
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
PUBMED
European Heart Journal: 37 (19), 1526-1534, 2016
15Forsea AM., Tschandl P., Del Marmol V., Zalaudek I., Soyer HP., Eurodermoscopy Working Group, Geller AC., Argenziano G.
Autorite grupp:Vahlberg A.
Factors driving the use of dermoscopy in Europe: a pan-European survey
PUBMED
British Journal of Dermatology: 175 (6), 1329-1337, 2016
16Gravanis I., Tzogani K., van Hennik P., de Graeff P., Schmitt P., Mueller-Berghaus J., Salmonson T., Gisselbrecht C., Laane E., Bergmann L., Pignatti F.
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Product for Human Use
PUBMED
Oncologist: 21 (1), 102-109, 2016
17Hallberg IR., Cabrera E., Jolley D., Raamat K., Renom-Guiteras A., Verbeek H., Soto ME., Stolt M., Karlsson S.
Professional care providers in dementia care in eight European countries; their training and involvement in early dementia stage and in home care
PUBMED
Dementia: 15 (5), 931-957, 2016
18Haring L., Müürsepp A., Mõttus R., Ilves P., Koch K., Uppin K., Tarnovskaja J., Maron E., Žarkovski A., Vasar E., Vasar V.
Cortical thickness and surface area correlates with cognitive dysfunction among first-episode psychosis patients
PUBMED
Psychological Medicine: 46 (10), 2145-2155, 2016
19Harro J., Oreland L.
The role of MAO in personality and drug use
PUBMED
Progress in Neuro-Psychopharmacology & Biological Psychiatry: 69, 101-111, 2016
20Henriques JPS., Hoebers LP., Ramunddal T., Laanmets P., Eriksen E., Bax M., Ioanes D., Suttorp MJ., Strauss BH., Barbato E., Nijveldt R., van Rossum AC., Marques KM., Elias J., van Dongen IM., Claessen BEPM., Tijssen JG., van der Schaaf RJ., EXPLORE Trial Investigators
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial
PUBMED
Journal of the American College of Cardiology: 68 (15), 1622-1632, 2016
21Howe AS., Buttenschon HN., Bani-Fatemi A., Maron E., Otowa T., Erhardt A., Binder EB., Gregersen NO., Mors O., Woldbye DP., Domschke K., Reif A., Šlik J., Kõks S., Kawamura Y., Miyashita A., Kuwano R., Tokunaga K., Tanii H., Smoller JW., Sasaki T., Koszycki D., De Luca V.
Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways
PUBMED
Molecular Psychiatry: 21 (5), 665-679, 2016
22Hulegardh E., Punab M., Holmberg E., Palk K., Laane E., Everaus H., Wennström L., Stockelberg D.
Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years
PUBMED
Acta Haematologica: 136 (3), 167-173, 2016
23Innos K., Valvere V., Padrik P., Eelma E., Kütner R., Lehtsaar J., Tekkel M.
Mammography Use and Mode of Detection Among Breast Cancer Patients in Estonia
PUBMED
Women & Health: 56 (2), 129-140, 2016
24Kadastik-Eerme L., Muldmaa M., Lilles S., Rosenthal M., Taba N., Taba P.
Nonmotor Features in Parkinson's Disease: What Are the Most Important Associated Factors?
PUBMED
Parkinson's Disease: 2016, Artikkel nr 4370674, 2016
25Kalle S., Tanner R., Arund J., Tomson R., Luman M., Fridolin I.
4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring
PUBMED
PLoS ONE: 11 (9), Artikkel nr e0162346, 2016
26Kim TW., Elme A., Kusic Z., Park JO., Udrea AA., Kim SY., Ahn JB., Valencia RV., Krishnan S., Bilic A., Manojlovic N., Dong J., Guan X., Lofton-Day C., Jung AS., Vrdoljak E.
A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer
PUBMED
British Journal of Cancer: 115 (10), 1206-1214, 2016
27Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castella M., Diener HC., Heidbuchel H., Hendriks J., Hindricks G., Manolis AS., Oldgren J., Popescu BA., Schotten U., Van Putte B., Vardas P., European Society of Cardiology (ESC) Scientific Document Group
Autorite grupp:Kampus P.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
PUBMED
European Heart Journal: 37 (38, SI), 2893-2962, 2016
28Kirkegaard H., Pedersen AR., Pettilä V., Hjort J., Rasmussen BS., de Haas I., Nielsen JF., Ilkjaer S., Kaltoft A., Jeppesen AN., Grejs AM., Duez CHV., Larsen AI., Toome V., Arus U., Taccone FS., Storm C., Laitio T., Skrifvars MB., Soreide E.
A statistical analysis protocol for the time-differentiated target temperature management after out-of-hospital cardiac arrest (TTH48) clinical trial
PUBMED
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine: 24 (1), Artikkel nr 138, 2016
29Kirkegaard H., Rasmussen BS., de Haas I., Nielsen JF., Ilkjaer S., Kaltoft A., Jeppesen AN., Grejs AM., Duez CHV., Larsen AI., Pettilä V., Toome V., Arus U., Taccone FS., Storm C., Skrifvars MB., Soreide E.
Time-differentiated target temperature management after out-of-hospital cardiac arrest: a multicentre, randomised, parallel-group, assessor-blinded clinical trial (the TTH48 trial): study protocol for a randomised controlled trial
PUBMED
Trials: 17, Artikkel nr 228, 2016
30Kõiv K., Metelitsa M., Vares M., Tiitsaar K., Raudkivi K., Jaako K., Vulla K., Shimmo R., Harro J.
Chronic variable stress prevents amphetamine-elicited 50-kHz calls in rats with low positive affectivity
PUBMED
European Neuropsychopharmacology: 26 (4), 631-643, 2016
31Lamy A., Devereaux PJ., Prabhakaran D., Taggart DP., Hu S., Straka Z., Piegas LS., Avezum A., Akar AR., Lanas Zanetti F., Jain AR., Noiseux N., Padmanabhan C., Bahamondes JC., Novick RJ., Tao L., Olavegogeascoechea PA., Airan B., Sulling TA., Whitlock RP., Ou Y., Gao P., Pettit S., Yusuf S., Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY) Investigators
Autorite grupp:Alver M., Sulling S., Vähi HV.
Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting
PUBMED
New England Journal of Medicine: 366 (16), 1489-1497, 2016
32Lankin V., Konovalova G., Tikhaze A., Shumaev K., Belova Kumskova E., Grechnikova M., Viigimaa M.
Aldehyde inhibition of antioxidant enzymes in the blood of diabetic patients
PUBMED
Journal of Diabetes: 8 (3), 398-404, 2016
33Lehto K., Mäestu J., Kiive E., Veidebaum T., Harro J.
BDNF Val66Met genotype and neuroticism predict life stress: A longitudinal study from childhood to adulthood
PUBMED
European Neuropsychopharmacology: 26 (3), 562-569, 2016
34Lincoff AM., Mehran R., Povsic TJ., Zelenkofske SL., Huang Z., Armstrong PW., Steg PG., Bode C., Cohen MG., Buller C., Laanmets P., Valgimigli M., Marandi T., Fridrich V., Cantor WJ., Merkely B., Lopez-Sendon JL., Cornel JH., Kasprzak JD., Aschermann M., Guetta V., Morais J., Sinnaeve PR., Huber K., Stables R., Sellers MA., Borgman M., Glenn L., Levinson AI., Lopes RD., Hasselblad V., Becker RC., Alexander JH., REGULATE-PCI Investigators
Autorite grupp:Uuetoa T.
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
PUBMED
The Lancet: 387 (10016), 349-356, 2016
35Lustenberger T., Talving P.
Focus on challenges and advances in the treatment of patients with penetrating injuries
PUBMED
European Journal of Trauma and Emergency Surgery: 42 (6), 661-662, 2016
36Maron E., Near J., Wallis G., Stokes M., Matthews PM., Nutt DJ.
A pilot study of the effect of short-term escitalopram treatment on brain metabolites and gamma-oscillations in healthy subjects
PUBMED
Journal of Psychopharmacology: 30 (6), 579-580, 2016
37Maron E., Wall M., Norbury R., Godlewska B., Terbeck S., Cowen P., Matthews PM., Nutt DJ.
Effect of short-term escitalopram treatment on neural activation during emotional processing
PUBMED
Journal of Psychopharmacology: 30 (1), 33-39, 2016
38Matrov D., Kõiv K., Kanarik M., Peet K., Raudkivi K., Harro J.
Middle-range exploratory activity in adult rats suggests higher resilience to chronic social defeat
PUBMED
Acta Neuropsychiatrica: 28 (3), 125-140, 2016
39McMurray JJ., Krum H., Abraham WT., Dickstein K., Kober LV., Desai AS., Solomon SD., Greenlaw N., Ali MA., Chiang Y., Shao Q., Tarnesby G., Massie BM., Aliskiren Trial to Minimize Outcomes in Patients with Heart Failure (ATMOSPHERE) Committees Investigators
Autorite grupp:Vettus R., Vahula V., Reimand M., Eha J.
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
PUBMED
New England Journal of Medicine: 374 (16), 1521-1532, 2016
40Meier J., Filipescu D., Kozek-Langenecker S., Llau Pitarch J., Mallett S., Martus P., Matot I., European Transfusion Practice and Outcome Study (ETPOS) collaborators
Autorite grupp:Karjagin J., Sõrmus A., Rokk A., Rätsep I., Kivik P., Smirnova N., Oganjan J.
Intraoperative transfusion practices in Europe
PUBMED
British Journal of Anaesthesia: 116 (2), 255-261, 2016
41Merisalu E., Animägi L., Oha K., Freimann T., Sirk T.
Job-Specific Factors and Prevalence of Multiple and Disabling Musculoskeletal Pain among Office Workers, Nurses, and Caregivers in Estonia
Proceedings of the Latvian Academy of Sciences: 70 (5), 286-293, 2016
42Misjuk M., Kaldmäe M., Annuk M., Viigimaa M.
Characteristics of leisure sports activity in a population with high cardio vascular disease mortality
Baltic Journal of Health and Physical Activity: 8 (1), 7-17, 2016
43Mohseni S., Bellander BM., Riddez L., Talving P., Thelin EP.
Positive blood alcohol level in severe traumatic brain injury is associated with better long-term functional outcome
PUBMED
Brain Injury: 30 (10), 1256-1260, 2016
44Nieminen MS., Buerke M., Cohen-Solal A., Costa S., Edes I., Erlikh A., Franco F., Gibson C., Gorjup V., Guarracino F., Gustafsson F., Harjola VP., Husebye T., Karason K., Katsytadze I., Kaul S., Kivikko M., Marenzi G., Masip J., Matskeplishvili S., Mebazaa A., Moller JE., Nessler J., Nessler B., Ntalianis A., Oliva F., Pichler-Cetin E., Põder P., Recio-Mayoral A., Rex S., Rokyta R., Strasser RH., Zima E., Pollesello P.
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
PUBMED
International Journal of Cardiology: 218, 150-157, 2016
45O'Donoghue ML., Glaser R., Cavender MA., Aylward PE., Bonaca MP., Budaj A., Davies RY., Dellborg M., Fox KAA., Gutierrez JA., Hamm C., Kiss RG., Kovar F., Kuder JF., Im KA., Lepore JJ., Lopez-Sendon JL., Ophuis TO., Parkhomenko A., Shannon JB., Spinar J., Tanguay JF., Ruda M., Steg PG., Theroux P., Wiviott SD., Laws I., Sabatine MS., Morrow DA., LATITUDE-TIMI 60 Investigators
Autorite grupp:Hedman A., Reinmets J., Soopõld Ü.
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial
PUBMED
JAMA, the Journal of the American Medical Association: 315 (15), 1591-1599, 2016
46O'Leary A., Kõiv K., Raudkivi K., Harro J.
Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour
PUBMED
Pharmacological Research: 113 (B, SI), 739-746, 2016
47Otsa M., Paaver M., Harro J., Bachmann T.
A Biomarker of Risk-Prone Behavioral Phenotype Correlates With Winning in a Game of Skill
Journal of Psychophysiology: 30 (4), 155-164, 2016
48Padari H., Oselin K., Tasa T., Metsvaht T., Lõivukene K., Lutsar I.
Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
PUBMED
BMC Pediatrics: 16, 206, 2016
49Panel Europeo de Expertos. Version Espanola del Grupo de trabajo sobre Dislipemia Aterogenica
Autorite grupp:Viigimaa M.
Consensus for pharmacologic treatment of atherogenic dyslipidemia with statin-fenofibrate combined therapy
PUBMED
Clinica e Investigacion en Arteriosclerosis: 28 (2), 87-93, 2016
50Pattaro C., Teumer A., Gorski M., Chu AY., Li M., Mijatovic V., Garnaas M., Tin A., Sorice R., Li Y., Taliun D., Olden M., Foster MC., Yang Q., Chen MH., Pers TH., Johnson AD., Ko YA., Fuchsberger C., Tayo B., Nalls MA., Feitosa MF., Isaacs A., Dehghan A., D'Adamo P., Adeyemo A., Dieffenbach AK., Zonderman AB., Nolte IM., van der Most PJ., Wright AF., Shuldiner AR., Morrison AC., Hofman A., Smith AV., Dreisbach AW., Franke A., Uitterlinden AG., Metspalu A., Tonjes A., Lupo A., Robino A., Johansson A., Demirkan A., Kollerits B., Freedman BI., Ponte B., Oostra BA., Paulweber B., Krämer BK., Mitchell BD., Buckley BM., Peralta CA., Hayward C., Helmer C., Rotimi CN., Shaffer CM., Müller C., Sala C., van Duijn CM., Saint Pierre A., Ackermann D., Shriner D., Ruggiero D., Toniolo D., Lu Y., Cusi D., Czamara D., Ellinghaus D., Siscovick DS., Ruderfer D., Gieger C., Grallert H., Rochtchina E., Atkinson EJ., Holliday EG., Boerwinkle E., Salvi E., Böttinger EP., Murgia F., Rivadeneira F., Ernst F., Kronenberg F., Hu FB., Navis GJ., Curhan GC., Ehret GB., Homuth G., Coassin S., Thun GA., Pistis G., Gambaro G., Malerba G., Montgomery GW., Eiriksdottir G., Jacobs G., Li G., Wichmann HE., Campbell H., Schmidt H., Wallaschofski H., Völzke H., Brenner H., Kroemer HK., Kramer H., Lin H., Leach IM., Ford I., Guessous I., Rudan I., Prokopenko I., Borecki I., Heid IM., Kolčic I., Persico I., Jukema JW., Wilson JF., Felix JF., Divers J., Lambert JC., Stafford JM., Gaspoz JM., Smith JA., Faul JD., Wang JJ., Ding J., Hirschhorn JN., Attia JR., Whitfield JB., Chalmers J., Viikari J., Coresh J., Denny JC., Karjalainen JM., Fernandes JK., Endlich K., Butterbach K., Keene KL., Lohman K., Portas L., Launer LJ., Lyytikäinen LP., Yengo L., Franke L., Ferrucci L., Rose LM., Kedenko L., Rao M., Struchalin M., Kleber ME., Cavalieri M., Haun M., Cornelis MC., Ciullo M., Pirastu M., de Andrade M., McEvoy MA., Woodward M., Adam M., Cocca M., Nauck M., Imboden M., Waldenberger M., Pruijm M., Metzger M., Stumvoll M., Evans MK., Sale MM., Kähönen M., Boban M., Bochud M., Rheinberger M., Verweij N., Bouatia-Naji N., Martin NG., Hastie ND., Probst-Hensch NM., Soranzo N., Devuyst O., Raitakari OT., Gottesman O., Franco OH., Polašek O., Gasparini P., Munroe PB., Ridker PM., Mitchell P., Muntner P., Meisinger C., Smit JH., International Consortium for Blood Pressure (ICBP), Asian Genetic Epidemiology Network (AGEN) Consortium, Coronary Artery Disease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium, Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium Heart Failure (CHARGE-HF) Working Group, ECHOGen Consortium, Kovacs P., Wild PS., Froguel P., Rettig R., Mägi R., Biffar R., Schmidt R., Middelberg RP., Carroll RJ., Penninx BWJH., Scott RJ., Katz R., Sedaghat S., Wild SH., Kardia SL., Ulivi S., Hwang SJ., Enroth S., Kloiber S., Trompet S., Stengel B., Hancock SJ., Turner ST., Rosas SE., Stracke S., Harris TB., Zeller T., Zemunik T., Lehtimäki T., Illig T., Aspelund T., Nikopensius T., Esko T., Tanaka T., Gyllensten U., Völker U., Emilsson V., Vitart V., Aalto V., Gudnason V., Chouraki V., Chen WM., Igl W., März W., Koenig W., Lieb W., Loos RJ., Liu Y., Snieder H., Pramstaller PP., Parsa A., O'Connell JR., Susztak K., Hamet P., Tremblay J., de Boer IH., Böger CA., Goessling W., Chasman DI., Köttgen A., Kao WH., Fox CS.
Autorite grupp:Veldre G., Viigimaa M., Org E., Sõber S., Laan M.
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
PUBMED
Nature Communications: 7, Artikkel nr 10023, 2016
51Pettai K., Milani L., Tammiste A., Võsa U., Kolde R., Eller T., Nutt DJ., Metspalu A., Maron E.
Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression
PUBMED
European Neuropsychopharmacology: 26 (9), 1475-1483, 2016
52Piepoli MF., Hoes AW., Agewall S., Albus C., Brotons C., Catapano AL., Cooney MT., Corra U., Cosyns B., Deaton C., Graham I., Hall MS., Hobbs R., Lochen ML., Löllgen H., Marques-Vidal P., Perk J., Prescott E., Redon J., Richter D., Sattar N., Smulders Y., Tiberi M., van der Worp HB., van Dis I., Verschuren WMM., Binno S., European Society of Cardiology (ESC) Scientific Document Group
Autorite grupp:Duishvili D.
2016 European Guidelines on cardiovascular disease prevention in clinical practice
PUBMED
European Heart Journal: 37 (29), 2315-2381, 2016
53Pille V., Oha K., Lauri M., Tint P., Tuulik Leisi VR., Tuulik V., Meigas K.
Prevention of Computer Worker Health Disturbances Caused by Physical and Physiological Risk
Proceedings of the Latvian Academy of Sciences: 70 (5), 308-314, 2016
54Pille V., Reinhold K., Tint P., Hartšenko J.
Comparison of musculoskeletal disorders development in Estonian office and garment industry workers
Agronomy Research: 14 (4), 1435-1449, 2016
55Pille V., Reinhold K., Tint P., Hartšenko J.
Musculoskeletal disorders caused by the static posture of office and garment workers
International Journal of Biology and Biomedical Engineering: 10, 191-201, 2016
56Plitt A., Ezekowitz MD., De Caterina R., Nordio F., Peterson N., Giugliano RP., ENGAGE AF-TIMI 48 Investigators
Autorite grupp:Kolk R., Laane E., Paumets M., Voitk J., Laheäär M.
Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48
PUBMED
Clinical Cardiology: 39 (6), 345-346, 2016
57Priori SG., Blomstrom-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., Elliott PM., Fitzsimons D., Hatala R., Hindricks G., Kirchhof P., Kjeldsen KP., Kuck KH., Hernandez-Madrid A., Nikolaou N., Norekval TM., Spaulding C., Van Veldhuisen DJ., ESC Committee for Practice Guidelines (CPG), Association for European Paediatric and Congenital Cardiology (AEPC)
Autorite grupp:Kampus P.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Journal of Immunology: 196 (7), 2793-2867, 2016
58Põldoja E., Rahu M., Kask K., Bulecza T., Weyers I., Kolts I.
Blood Supply of the Superior Glenohumeral Ligament: A Gross Anatomical and Histological Study
Austin Journal of Anatomy: 3 (1), Artikkel nr 1048, 2016
59Pääsuke R., Eimre M., Piirsoo A., Peet N., Laada L., Kadaja L., Roosimaa M., Pääsuke M., Märtson A., Seppet E., Paju K.
Proliferation of Human Primary Myoblasts Is Associated with Altered Energy Metabolism in Dependence on Ageing In Vivo and In Vitro
PUBMED
Oxidative Medicine and Cellular Longevity: 2016, Artikkel nr 8296150, 2016
60Pym AS., Diacon AH., Tang SJ., Conradie F., Danilovitš M., Chuchottaworn C., Vasilyeva I., Andries K., Bakare N., De Marez T., Haxaire-Theeuwes M., Lounis N., Meyvisch P., Van Baelen B., van Heeswijk RP., Dannemann B., TMC207-C209 Study Group
Autorite grupp:Kurve A.
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
PUBMED
European Respiratory Journal: 47 (2), 564-574, 2016
61Riispere Ž., Laurinavičius A., Kuudeberg A., Seppet E., Sepp K., Ilmoja M., Luman M., Kõlvald K., Auerbach A., Ots-Rosenberg M.
IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences
PUBMED
Medicina (Lithuania): 52 (6), 340-348, 2016
62Roffi M., Patrono C., Collet JP., Mueller C., Valgimigli M., Andreotti F., Bax JJ., Borger MA., Brotons C., Chew DP., Gencer B., Hasenfuss G., Kjeldsen KP., Lancellotti P., Landmesser U., Mehilli J., Mukherjee D., Storey RF., Windecker S., Baumgartner H., Gaemperli O., Achenbach S., Agewall S., Badimon L., Baigent C., Bueno H., Bugiardini R., Carerj S., Casselman F., Cuisset T., Erol C., Fitzsimons D., Halle M., Hamm C., Hildick-Smith D., Huber K., Iliodromitis E., James S., Lewis BS., Lip GY., Piepoli MF., Richter D., Rosemann T., Sechtem U., Steg PG., Vrints C., Zamorano JL., Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology
Autorite grupp:Marandi T.
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
PUBMED
European Heart Journal: 37 (3), 267-315, 2016
63Rost NS., Giugliano RP., Ruff CT., Murphy SA., Crompton AE., Norden AD., Silverman S., Singhal AB., Nicolau JC., SomaRaju B., Mercuri MF., Antman EM., Braunwald E., ENGAGE AF-TIMI 48 Investigators
Autorite grupp:Kolk R., Laane E., Paumets M., Voitk J., Laheäär M.
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
PUBMED
Stroke: 47 (8), 2075-2082, 2016
64Saar S., Merioja I., Lustenberger T., Lepner U., Asser T., Metsvaht T., Ilmoja ML., Kukk L., Starkopf J., Talving P.
Severe Trauma in Estonia: 256 consecutive cases analysed and the impact on outcomes comparing two regions
PUBMED
European Journal of Trauma and Emergency Surgery: 42 (4), 497-502, 2016
65Saar S., Talving P., Laos J., Põdramägi T., Sokirjanski M., Lustenberger T., Lam L., Lepner U.
Delay Between Onset of Symptoms and Surgery in Acute Appendicitis Increases Perioperative Morbidity: A Prospective Study
PUBMED
World Journal of Surgery: 40 (6), 1308-1314, 2016
66Sabre L., Harro J., Eensoo D., Vaht M., Kabel V., Pakkanen M., Asser T., Kõrv J.
A new risk factor for traumatic spinal cord injury
PUBMED
Journal of Neurotrauma: 33 (21), 1946-1949, 2016
67Sarquis LM., Coggon D., Ntani G., Walker-Bone K., Palmer KT., Felli VE., Harari R., Barrero LH., Felknor SA., Gimeno D., Cattrell A., Vargas-Prada S., Bonzini M., Solidaki E., Merisalu E., Habib RR., Sadeghian F., Kadir MM., Warnakulasuriya SS., Matsudaira K., Nyantumbu B., Sim MR., Harcombe H., Cox K., Marziale MH., Harari F., Freire R., Harari N., Monroy MV., Quintana LA., Rojas M., Harris EC., Serra C., Martinez JM., Delclos G., Benavides FG., Carugno M., Ferrario MM., Pesatori AC., Chatzi L., Bitsios P., Kogevinas M., Oha K., Sadeghian A., Peiris-John RJ., Sathiakumar N., Wickremasinghe AR., Yoshimura N., Kelsall HL., Hoe VCW., Urquhart DM., Derrett S., McBride D., Herbison P., Gray A., Salazar Vega EJ., Freimann T.
Classification of neck/shoulder pain in epidemiological research: a comparison of personal and occupational characteristics, disability, and prognosis among 12,195 workers from 18 countries
PUBMED
Pain: 157 (5), 1028-1036, 2016
68Sartelli M., Weber DG., Ruppe E., Bassetti M., Wright BJ., Ansaloni L., Catena F., Coccolini F., Abu-Zidan FM., Coimbra R., Moore EE., Moore FA., Maier RV., De Waele JJ., Kirkpatrick AW., Griffiths EA., Eckmann C., Brink AJ., Mazuski JE., May AK., Sawyer RG., Mertz D., Montravers P., Kumar A., Roberts JA., Vincent JL., Watkins RR., Lowman W., Spellberg B., Abbott IJ., Adesunkanmi AK., Al-Dahir S., Al-Hasan MN., Agresta F., Althani AA., Ansari S., Ansumana R., Augustin G., Bala M., Balogh ZJ., Baraket O., Bhangu A., Beltran MA., Bernhard M., Biffl WL., Boermeester MA., Brecher SM., Cherry-Bukowiec JR., Buyne OR., Cainzos MA., Cairns KA., Camacho-Ortiz A., Chandy SJ., Che Jusoh A., Chichom-Mefire A., Colijn C., Corcione F., Cui Y., Curcio D., Delibegovic S., Demetrashvili Z., De Simone B., Dhingra S., Diaz JJ., Di Carlo I., Dillip A., Di Saverio S., Doyle MP., Dorj G., Dogjani A., Dupont H., Eachempati SR., Enani MA., Egiev V., Elmangory MM., Ferrada P., Fitchett JR., Fraga GP., Guessennd N., Giamarellou H., Ghnnam W., Gkiokas G., Goldberg SR., Gomes CA., Gomi H., Guzman-Blanco M., Haque M., Hansen S., Hecker A., Heizmann WR., Herzog T., Hodonou AM., Hong SK., Kafka-Ritsch R., Kaplan LJ., Kapoor G., Karamarkovic A., Kees MG., Kenig J., Kiguba R., Kim PK., Kluger Y., Khokha V., Koike K., Kok KYY., Kong V., Knox MC., Inaba K., Isik A., Iskandar KA., Ivatury RR., Labbate M., Labricciosa FM., Laterre PF., Latifi R., Lee JG., Lee YR., Leone M., Leppaniemi A., Li Y., Liang SY., Loho T., Maegele M., Malama S., Marei HE., Martin-Loeches I., Marwah S., Massele A., McFarlane ME., Melo RB., Negoi I., Nicolau DP., Nord CE., Ofori-Asenso R., Omari AH., Ordonez CA., Ouadii M., Pereira GA. Jr., Piazza D., Pupelis G., Rawson TM., Rems M., Rizoli S., Rocha C., Sakakushev B., Sanchez-Garcia M., Sato N., Segovia Lohse HA., Sganga G., Siribumrungwong B., Shelat VG., Soreide K., Soto R., Talving P., Tilsed JV., Timsit JF., Trueba G., Trung NT., Ulrych J., van Goor H., Vereczkei A., Vohra RS., Wani I., Uhl W., Xiao Y., Yuan KC., Zachariah SK., Zahar JR., Zakrison TL., Corcione A., Melotti RM., Viscoli C., Viale P.
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
PUBMED
World Journal of Emergency Surgery: 11, Artikkel nr 33, 2016
69Simpson EL., Bieber T., Guttman-Yassky E., Beck LA., Blauvelt A., Cork MJ., Silverberg JI., Deleuran M., Kataoka Y., Lacour JP., Kingo K., Worm M., Poulin Y., Wollenberg A., Soo Y., Graham NMH., Pirozzi G., Akinlade B., Staudinger H., Mastey V., Eckert L., Gadkari A., Stahl N., Yancopoulos GD., Ardeleanu M., SOLO and SOLO 2 Investigators
Autorite grupp:Konno P., Pender K., Põder A., Vahlberg A.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
PUBMED
New England Journal of Medicine: 375 (24), 2335-2348, 2016
70Szkultecka-Debek M., Miernik K., Stelmachowski J., Jakovljevic M., Jukic V., Aadamsoo K., Janno S., Bitter I., Tolna J., Jarema M., Jankovic S., Pecenak J., Vavrusova L., Tavčar R., Walczak J., Talbot D., Augustynska J.
Schizophrenia Causes Significant Burden to Patients' and Caregivers' Lives
PUBMED
Psychiatria Danubina: 28 (2), 104-110, 2016
71Szkultecka-Debek M., Miernik K., Stelmachowski J., Jakovljevic M., Jukic V., Aadamsoo K., Janno S., Bitter I., Tolna J., Jarema M., Jankovic S., Pecenak J., Vavrusova L., Tavčar R., Walczak J., Talbot D., Augustynska J.
Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries
PUBMED
Psychiatria Danubina: 28 (3), 234-242, 2016
72Strumwasser A., Speer AL., Inaba K., Branco BC., Upperman JS., Ford HR., Lam L., Talving P., Shulman I., Demetriades D.
The impact of acute coagulopathy on mortality in pediatric trauma patients
PUBMED
Journal of Trauma and Acute Care Surgery: 81 (2), 312-318, 2016
73Zagura M., Kals J., Paapstel K., Serg M., Kampus P., Eha J., Zilmer M.
Response to Aboyans, et al.: Estimation of pulse wave velocity in patients with peripheral artery disease: a word of caution
PUBMED
Hypertension Research: 39 (8), 618-619, 2016
74Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A., Scotti L., Zhang X., Guan TR., Zhang Y., Zhang X., Berge E., Redon J., Narkiewicz K., Dominiczak AF., Nilsson PM., Viigimaa M., Laurent S., Agabiti Rosei E., Wu Z., Zhu D., Rodicio JL., Ruilope LM., Martell-Claros N., Pinto F., Schmieder RE., Burnier M., Banach M., Cifkova R., Farsang C., Konradi A., Lazareva I., Sirenko Y., Dorobantu M., Postadzhiyan A., Accetto R., Jelakovic B., Lovic D., Manolis AJ., Stylianou P., Dicker D., Wei G., Xu C., Xie H., Coca A., O'Brien J., Ford GA., Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives (ESH-CHL-SHOT) trial investigators
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke
PUBMED
Journal of Hypertension: 34 (3), 393-396, 2016
75Talving P., Ilmoja ML., Taal G., Isand KG., Teppo S., Noor EH., Kruusat R., Remmelgas A., Saar S.
Blunt cardiac rupture in a toddler
Journal of Pediatric Surgery Case Reports: 11, 1-3, 2016
76Talving P., Rauk M., Vipp L., Isand KG., Šamarin A., Põder K., Rätsep I., Saar S.
Necrosis of the tail of pancreas following proximal splenic artery embolization
PUBMED
Journal of Surgical Case Reports: 5, Artikkel nr rjw087, 2016
77Talving P., Saar S., Lam L.
Management of Penetrating Trauma to the Major Abdominal Vessels
Current Trauma Reports: 2 (1), 21-28, 2016
78Tamm G., Kreegipuu K., Harro J.
Perception of emotion in facial stimuli: The interaction of ADRA2A and COMT genotypes, and sex
PUBMED
Progress in Neuro-Psychopharmacology & Biological Psychiatry: 64, 87-95, 2016
79Tamme K., Oselin K., Kipper K., Tasa T., Metsvaht T., Karjagin J., Herodes K., Kern HR., Starkopf J.
Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock
PUBMED
Acta Anaesthesiologica Scandinavica: 60 (2), 230-240, 2016
80Toft N., Birgens H., Abrahamsson J., Griškevičius L., Hallböök H., Heyman M., Klausen TW., Jonsson OG., Palk K., Pruunsild K., Quist-Paulsen P., Vaitkevičiene GE., Vettenranta K., Asberg A., Helt LR., Frandsen TL., Schmiegelow K.
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia
PUBMED
European Journal of Haematology: 96 (2), 160-169, 2016
81Tomson K., Vaht M., Laas K., Veidebaum T., Harro J.
Effect of a human serotonin 5-HT2A receptor gene polymorphism on impulsivity: Dependence on cholesterol levels
PUBMED
Journal of Affective Disorders: 206, 23-30, 2016
82Tucker S., Brand C., Sutcliffe C., Challis D., Saks K., Verbeek H., Cabrera E., Karlsson S., Leino-Kilpi H., Stephan A., Soto ME., RightTimePlaceCare (RTPC) Consortium
Autorite grupp:Tiit EM., Leibur J., Raamat K., Armolik A., Toivari TTM.
What Makes Institutional Long-Term Care the Most Appropriate Setting for People With Dementia? Exploring the Influence of Client Characteristics, Decision-Maker Attributes, and Country in 8 European Nations
PUBMED
Journal of the American Medical Directors Association: 17 (5), Artikkel nr 465.e9, 2016
83Vaht M., Kiive E., Veidebaum T., Harro J.
A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study
PUBMED
International Journal of Neuropsychopharmacology: 19 (7), 2016
84Vaht M., Kurrikoff T., Laas K., Veidebaum T., Harro J.
Oxytocin receptor gene variation rs53576 and alcohol abuse in a longitudinal population representative study
PUBMED
Psychoneuroendocrinology: 74, 333-341, 2016
85Vallersnes OM., Dines AM., Wood DM., Yates C., Heyerdahl F., Hovda KE., Giraudon I., European-Drug Emergencies Network (Euro-DEN) Research Group, Dargan PI.
Autorite grupp:Paasma R., Põld K.
Psychosis associated with acute recreational drug toxicity: a European case series
PUBMED
BMC Psychiatry: 16, Artikkel nr 293, 2016
86Vansteenkiste JF., Cho BC., Vanakesa T., De Pas T., Zielinski M., Kim MS., Jassem J., Yoshimura M., Dahabreh J., Nakayama H., Havel L., Kondo H., Mitsudomi T., Zarogoulidis K., Gladkov O., Udud K., Tada H., Hoffman H., Bugge A., Taylor P., Gonzalez EE., Liao ML., He J., Pujol JL., Louahed J., Debois M., Brichard VG., Debruyne C., Therasse P., Altorki N.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
PUBMED
The Lancet Oncology: 17 (6), 822-835, 2016
87Vargas-Prada S., Coggon D., Ntani G., Walker-Bone K., Palmer KT., Felli VE., Harari R., Barrero LH., Felknor SA., Gimeno D., Cattrell A., Bonzini M., Solidaki E., Merisalu E., Habib RR., Sadeghian F., Kadir MM., Warnakulasuriya SS., Matsudaira K., Nyantumbu B., Sim MR., Harcombe H., Cox K., Sarquis LM., Marziale MH., Harari F., Freire R., Harari N., Monroy MV., Quintana LA., Rojas M., Harris EC., Serra C., Martinez JM., Delclos G., Benavides FG., Carugno M., Ferrario MM., Pesatori AC., Chatzi L., Bitsios P., Kogevinas M., Oha K., Freimann T., Sadeghian A., Peiris-John RJ., Sathiakumar N., Wickremasinghe AR., Yoshimura N., Kelsall HL., Hoe VCW., Urquhart DM., Derrett S., McBride D., Herbison P., Gray A., Vega EJ.
Descriptive Epidemiology of Somatising Tendency: Findings from the CUPID Study
PUBMED
PLoS ONE: 11 (4), Artikkel nr e0153748, 2016
88Vedin O., Hagström E., Budaj A., Denchev S., Harrington RA., Koenig W., Soffer J., Sritara P., Stebbins A., Stewart R., Swart HP., Viigimaa M., Vinereanu D., Wallentin L., White HD., Held C., Stabilization of Atherosclerotic Plaque By Initiation of Darapladib Therapy (STABILITY) Investigators
Tooth loss is independently associated with poor outcomes in stable coronary heart disease
PUBMED
European Journal of Preventive Cardiology: 23 (8), 839-846, 2016
89Wallentin L., Held C., Armstrong PW., Cannon CP., Davies RY., Granger CB., Hagström E., Harrington RA., Hochman JS., Koenig W., Krug-Gourley S., Mohler ER. 3rd, Siegbahn A., Tarka E., Steg PG., Stewart R., Weiss R., Östlund O., White HD., Stabilization of Atherosclerotic Plaque By Initiation of Darapladib Therapy (STABILITY) Investigators
Autorite grupp:Viigimaa M.
Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease
PUBMED
Journal of the American Heart Association: 5 (6), Artikkel nr e003407, 2016
90Wanner C., Inzucchi SE., Lachin JM., Fitchett D., von Eynatten M., Mattheus M., Johansen OE., Woerle HJ., Broedl UC., Zinman B., EMPA-REG OUTCOME Investigators
Autorite grupp:Lubi M., Marandi T.
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
PUBMED
New England Journal of Medicine: 375 (4), 323-334, 2016
91Waris E., Mattila S., Sillat T., Karjalainen T.
Extension Block Pinning for Unstable Proximal Interphalangeal Joint Dorsal Fracture Dislocations
PUBMED
Journal of Hand Surgery (American Volume): 41 (2), 196-202, 2016
92Wedzicha JA., Banerji D., Chapman KR., Vestbo J., Roche N., Ayers RT., Thach C., Fogel R., Patalano F., Vogelmeier CF., FLAME Investigators
Autorite grupp:Jõgi R., Meren M., Samarüütel P.
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD
PUBMED
New England Journal of Medicine: 374 (23), 2222-2234, 2016
93Yabe D., Ambos A., Cariou B., Duvnjak L., Evans M., Gonzalez-Galvez G., Lin J., Nikonova E., De Pablos-Velasco P., Yale JF., Ahren B.
Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse beta-cell function in the GetGoal-M and GetGoal-S trials
PUBMED
Journal of Diabetes and its Complications: 30 (7), 1385-1392, 2016
Artiklid "Eesti Arstis"
1Adamson A., Oselin K.
Immuunteraapia onkoloogias
Eesti Arst: 95 (6), 401-405, 2016
2Ambos A., Raie E., Kiudma T., Reppo I., Rätsep A., Tammiksaar K., Toomsoo T., Volke V.
2. tüüpi diabeedi Eesti ravijuhend 2016
Eesti Arst: 95 (7), 465-473, 2016
3Anton L.
Erialauudised. Pulmonoloogia. Ülevaade pulmonaalhüpertensiooni erinevate vormide ravi võimalustest
Eesti Arst: 95 (4), 257-260, 2016
4Eino K., Saluveer E.
Psühhoosihaigele võimaldatud nüüdisaegne toetusravi toob kasu nii haigele kui ka ühiskonnale
Eesti Arst: 95 (3), 151-153, 2016
5Jaanson T.
Ajuveresoonte seisund migreenihoo ajal. Magnetresonantstomograafia võimalused selle visualiseerimiseks
Eesti Arst: 95 (11), 734-735, 2016
6Kiisk K., Nõmm K., Lotman EM., Talving P., Starkopf J.
Vereseerumi troponiini määramine erakorralises meditsiinis
Eesti Arst: 95 (8), 515-522, 2016
7Kõrv J., Heinsoo M., Kreis A., Kullamaa S., Liigant A., Õunapuu A.
Kliinilise järelauditi „Insuldiravi põhjendatus ja kvaliteet Eesti haiglates“ kokkuvõte
Eesti Arst: 95 (1), 17-19, 2016
8Kütt M., Valvere V.
Vereseerumi kasvajamarkerite kasutamine kliinilises praktikas
Eesti Arst: 95 (9), 597-603, 2016
9Laurik J.
Kienböcki tõbi
Eesti Arst: 95 (10), 658-659, 2016
10Palumaa T., Palumaa K.
Erialauudised. Silmahaigused
Eesti Arst: 95 (2), 120-121, 2016
11Pauklin P., Kampus P.
Erialauudised. Kardioloogia
Eesti Arst: 95 (11), 737-741, 2016
12Reile R., Kõrv J., Voitk J., Uuetoa T., Alloja J., Võrno T., Lutsar K., Aleksandrova J., Tootsi K., Kiivet RA.
Antikoagulandid virvendusarütmia tüsistuste ennetamisel Eestis – kulutõhusus ja maksumus
Eesti Arst: 95 (11), 709-715, 2016
13Reimand J.
Primaarne duraalne lümfoom
Eesti Arst: 95 (5), 332-333, 2016
14Roosimaa M.
Diabeedi ravi ja kardiovaskulaarne risk
Eesti Arst: 95 (10), 667-670, 2016
15Semjonov K.
Pulmonaalne alveolaarne proteinoos
Eesti Arst: 95 (6), 399-400, 2016
16Sipria A., Kirsimägi Ü., Popov A., Veber A.
Taaselustamine haiglaväliselt tekkinud südame äkksurmast. Tulemused Eestis aastatel 1999–2013
Eesti Arst: 95 (7), 428-436, 2016
17Talving P., Mihnovitš V., Lepner U., Saar S.
Ägeda apenditsiidi tänapäevane käsitlus
Eesti Arst: 95 (11), 723-727, 2016
18Tuusov J., Tõnisson M., Vassiljev V.
Seleenimürgistus. Lahangujuhtude kirjeldus
Eesti Arst: 95 (2), 109-111, 2016
19Vettus E., Oselin K.
Febriilne neutropeenia – keemiaravi sage ja potentsiaalselt eluohtlik kõrvaltoime
Eesti Arst: 95 (3), 188-193, 2016
20Viigimaa M.
Traditsioonilised ja uued ravimid aterogeense düslipideemia ravis
Eesti Arst: 95 (5), 299-306, 2016
21Väli M., Jõeste E.
Surma põhjuse määramine ja selle õiguslik alus
Eesti Arst: 95 (1), 62-66, 2016
Raamatud, dissertatsioonid
1Oselin K., Pintson M., Vettus E., Kutsar A., Kiivet RA.
Kopsukasvajate kemoteraapia kliiniline tõenduspõhisus ja kulutõhusus: tervisetehnoloogia hindamise raport TTH28
Kopsukasvajate kemoteraapia kliiniline tõenduspõhisus ja kulutõhusus: tervisetehnoloogia hindamise raport TTH28: 97, 2016
Kogumikuartiklid, peatükid raamatus
1Hazak A., Virkebau M., Tuulik V., Tint P., Pille V., Sõõru E.
Social Innovation Potential in Working Arrangements of R&D Employees: Repeated Employee Survey from Estonia
2016 IEEE International Conference on Emerging Technologies and Innovative Business Practices for the Transformation of Societies (EmergiTech): 210-213, 2016
Konverentsiteesid
1Abram M., Leismann T.
Autoimmune lymphoproliferative syndrome caused by a rare mutation of the FAS gene: A case report
Virchows Archiv: 469 (Suppl 1), S112-S112, 2016
2Areda T., Paal A., Asser A., Korjus K.
What should on-call paediatric surgeon know about CSF shunts? Hardware and related complications
XIV Conference of the Baltic Association of Paediatric Surgeons: May 5th-8th, 2016 Tartu, Estonia: programme and abstract book: 46-46, 2016
3Boutouyrie P., Elmula F., Rebora P., Talvik A., Salerno S., Miszkowska-Nagorna E., Liuc X., Comotti T., Larstorp AC., Rostrup M., Qwierblewska E., Valsecchi M., Kjeldsen SE., Viigimaa M., Narkiewicz K., Parati G., Laurent S.
Non-Invasive hemodynamic monitoring in uncontrolled hypertensive patients: effect on arterial stiffness and central blood pressure: the BEAUTY study
Journal of Hypertension: 34 (Suppl 2), e111-e111, 2016
4Candemir E., Kollert L., Weissflog L., Geis M., Müller A., Post AM., O'Leary A., Harro J., Reif A., Freudenberg F.
Interaction of nitric oxide synthase 1 with its adaptor protein: effects on schizophrenia-related dendritic alterations
European Neuropsychopharmacology: 26 (Suppl 1), S9-S10, 2016
5Corbalan R., Ruff C., Duris T., Juul-Möller S., Voitk J., Trevisan M., Antman E., Braunwald E., Giugliano RP.
Edoxaban Associated With Fewer Serious Adverse Events and Lower Mortality Than Warfarin, Regardless of Burden of Comorbidities: Insights From the ENGAGE AF-TIMI 48 Trial
Circulation: 134 (Suppl 1), Tees nr 16587, 2016
6Gerškevitš E., Boka G.
Comparison of two unshielded diodes for commissioning of Cyberknife
Radiotherapy and Oncology: 119 (Suppl 1), S695-S696, 2016
7Gerškevitš E., Zolotuhhin D.
Planar KV Imaging Dose Reduction Study
Medical Physics: 43 (6), 3409-3409, 2016
8Gordin D., Elmula FEF., Andersson B., Gottsater A., Kahan T., Viigimaa M., Kjeldsen SE., Christensen KL., Olsen MH., Tikkanen I.
The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension - the rationale and design of the Nordic BAT study
Journal of Hypertension: 34 (Suppl 2), E193-E193, 2016
9Hade J., Ilmoja ML.
Epidemiology of severe traumatic brain injury in Tallinn Children's Hospital: a comparison of two five-year periods
XIV Conference of the Baltic Association of Paediatric Surgeons: May 5th-8th, 2016 Tartu, Estonia: programme and abstract book: 78-78, 2016
10Ilmoja ML., Asser A., Paal A.
Kesknärvisüsteemi infektsioon hüdrotsefaalia tõttu opereeritud lastel
Eesti Lastearstide Seltsi XXI kongress 2.–4. juuni 2016, Tallinn: 21-21, 2016
11Joost K., Tomberg K., Saks K., Hein H., Roht L., Zordania R.
A case of mucopolysaccharidosis type VII presenting with gingival hypertrophy
Journal of Inherited Metabolic Disease: 39 (1, Suppl), S266-S266, 2016
12Jürisson M., Lehtmets A., Julge K.
Allergilise kontaktdermatiidi põhjused lastel
Eesti Lastearstide Seltsi XXI kongress 2.–4. juuni 2016, Tallinn: 46-46, 2016
13Kim TW., Elme A., Kusic Z., Park JO., Udrea AA., Kim SY., Ahn JB., Valencia RV., Srinivasan K., Bilic A., Manojlovic N., Dong J., Guan XS., Lofton-Day C., Jung AS., Vrdoljak E.
An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC
Journal of Clinical Oncology: 34 (4, Suppl S), Tees nr 642, 2016
14Kim TW., Elme A., Kusic Z., Park JO., Udrea AA., Kim SY., Ahn JB., Valencia RV., Srinivasan K., Bilic A., Manojlovic N., Dong J., Guan XS., Lofton-Day C., Jung AS., Vrdoljak E.
Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC)
Journal of Clinical Oncology: 34 (15, Suppl S), Tees nr 3536, 2016
15Kink A., Rätsep I.
Brain compartment monitoring capabilities from ICP to BI (bioimpedance) during HS (hypertonic saline) administration. State of art simulation outcome depending on brain swelling type
Critical Care: 20 (Suppl 2), 140-140, 2016
16Korotõtš D., Valk E., Kukk L.
The comparison of results of systematic transrectal prostate biopsy performed by urologists and radiologists
European Urology Supplements: 15 (5), Tees nr e1175, 2016
17Kõiv K., Kroon C., Tiitsaar K., Metelitsa M., Raudkivi K., Paesüld A., Harro J.
The effect of chronic variable stress on amphetamine sensitization in high and low sucrose consuming rats
European Neuropsychopharmacology: 26 (Suppl 2), S248-S248, 2016
18Laane E., Raudsepp K., Everaus H., Punab M.
Efficacy of Generic Imatinib in Newly Diagnosed Cp-Cml Patients in Estonian Population
Haematologica: 101 (Suppl 1), 741-741, 2016
19Lauri K., Luman M., Holmar J., Tomson R., Kalle S., Arund J., Uhlin F., Fridolin I.
Can Removal of Middle Molecular Uremic Retention Solutes be Estimated by UV-absorbance Measurements in Spent Dialysate?
Onsite Program. 2015 World Congress on Medical Physics and Biomedical Engineering: 488-488, 2016
20Lehto K., Laas K., Veidebaum T., Harro J.
BDNF gene variant Val66Met and personality predict future stressful life events: a longitudinal study
European Neuropsychopharmacology: 26 (Suppl 2), S184-S185, 2016
21Lehto K., Laas K., Veidebaum T., Harro J.
The brain-derived neurotrophic factor gene variant Val66Met and personality predict stressful life events
European Neuropsychopharmacology: 26 (Suppl 1), S79-S80, 2016
22Lellep A., Kurm J., Univer I., Kool P., Tomberg K.
Comparison of blood sample transport via pneumatic tube system and manually by courier
Eesti Arst: 95 (Lisa 1), 53-53, 2016
23Levina K.
Prevalence of non-tuberculous mycobacterium strains isolated from clinical specimens at North Estonia Medical Centre 2001-2015
Eesti Arst: 95 (Lisa 1), 54-54, 2016
24Melnikova R., Lenskaja A., Kurvits S., Pilden-Sarv B., Julge K., Sergejeva S.
Monotsüütide osalusest väikelaste astma riski suurendamisel antenataalse ja postnataalse passiivse suitsetamise korral
Eesti Lastearstide Seltsi XXI kongress 2.–4. juuni 2016, Tallinn: 53-53, 2016
25Mäestu J., Lätt E., Vaht M., Jürimäe J., Harro J.
Kehalise fitnessi seosed metaboolse sündroomi riskiteguritega 18aastastel eestlastel
Eesti Arst: 95 (Lisa 2), 20-20, 2016
26Männik A., Suuroja T., Kiivet RA.
Colorectal Cancer Treatment Costs in Estonia
Value in Health: 19 (7), A610-A610, 2016
27Paal A., Poola M., Juurmaa R., Pappa L., Areda T., Asser A.
National Neural Tube Defects Registry (NTDR): Development of a Data Managemen
XIV Conference of the Baltic Association of Paediatric Surgeons: May 5th-8th, 2016 Tartu, Estonia: programme and abstract book: 47-48, 2016
28Padari H., Metsvaht T., Ilmoja ML., Hallik M., Kipper K., Herodes K., Oselin K., Tasa T., Lutsar I.
Ampitsilliini farmakokineetika (FK) vastsündinutel esimestel elupäevadel
Eesti Lastearstide Seltsi XXI kongress 2.–4. juuni 2016, Tallinn: 60-60, 2016
29Paju K., Põdramägi T., Peet N., Eimre M., Kadaja L., Roosimaa M., Piirsoo A., Seppet E., Ruusalepp A.
Increased complex I dependent respiration and increased restriction for ADP in volume overload-induced atrial dilatation
Journal of Molecular and Cellular Cardiology: 98 (Suppl), S56-S56, 2016
30Pern T., Põder P., Adoberg A., Hein L., Lotman EM., Lubi R., Majas R., Püvi K., Teppand P., Marandi T.
Drug therapy recommendations at discharge in patients with heart failure - do we follow ESC guidelines in Estonia
European Journal of Heart Failure: 18 (Suppl 1, SI), 336-337, 2016
31Petuhov A., Vaide I., Laane E., Osterholm K., Armstrong AE., Lassila R., Karp K.
Comparison of Joint Health in Adult Hemophilia Patients Within WFH Twinning Program Tallinn - Helsinki
Haemophilia: 22 (Suppl 2, SI), 32-33, 2016
32Pikta M.
Screening for hemoglobinopathies
Eesti Arst: 95 (Lisa 1), 28-28, 2016
33Pikta M., Banys V., Laane E., Vaide I., Zolotarjova V., Titova T., Karp K.
Evaluation of Von Willebrand Factor Activity Assay in Comparision with "Gold Standard" Assay
Haemophilia: 22 (Suppl 2, SI), 25-26, 2016
34Pikta M., Tõnne J., Tirkkonen N., Marandi T., Arjakse J., Viigimaa M.
Rivaroxaban: evaluation of analytical performance
Clinical Chemistry and Laboratory Medicine: 54 (10), eA259-eA260, 2016
35Pompilio P., Zanaboni P., Bergmo T., Grzetic-Romcevic T., Isetta V., Janson C., Malinovschi A., Marusic D., Middlemass J., Montserrat J., Munaro G., Prikk K., Sepper R., Siriwardena AN., Calverley P., Dellaca R., Rosso R., Walker P.
Randomised controlled trial of telemonitoring with addition of daily forced oscillation in older people with COPD and co-morbidity
European Respiratory Journal: 48 (Suppl 60), Tees nr OA3519, 2016
36Rahu M., Kolts I., Põldoja H., Kask K.
Rotator cuff tendon connections with the rotator cable
Knee Surgery, Sports Traumatology, Arthroscopy: 24 (Suppl 1), S216, 2016
37Ramachandran H., Salum E., Kampus P., Kals J., Town G., Avolio AP., Butlin M.
Baroreceptor Sensitivity in Diabetic Rats with Treated and Untreated Hypertension
Hypertension: 67 (5), E18-E18, 2016
38Riispere Ž., Kuudeberg A., Seppet E., Sepp K., Ilmoja M., Luman M., Kõlvald K., Auerbach A., Ots-Rosenberg M.
The impact of clinical and morphological prognostic risk factors theprediction of renal outcome in patients with immunoglobulin a nephropathy
Nephrology Dialysis Transplantation: 31 (Suppl 1), 1422-1423, 2016
39Rozenblat V., Ng D., Fuller-Tyszkiewicz M., Akkermann K., Collier DA., Engels RCME., Fernandez-Aranda F., Harro J., Karwautz A., Homberg J., Klump KL., Racine SE., Larson CL., Steiger H., Richardson J., Stoltenberg SF., van Strien T., Wagner G., Treasure J., Krug I.
A meta-analysis of gene (5-HTT) × environment interactions in eating pathology using secondary data analyses
European Psychiatry: 33 (Suppl), S83-S83, 2016
40Saar A., Läll K., Alver M., Fischer K., Marandi T., Ainla T., Eha J.
Accuracy of PCE, SCORE and QRISK2 scores in predicting cardiovascular disease in Estonia, a high risk European country
European Heart Journal: 37 (Suppl 1), 1217-1217, 2016
41Saar S., Laos J., Ilmoja ML., Metsvaht T., Laasma M., Märtson M., Sokirjanski M., Varik K., Talving P.
Population-based pediatric trauma in Estonia: Forty-eight consecutive cases analyzed
XIV Conference of the Baltic Association of Paediatric Surgeons: May 5th-8th, 2016 Tartu, Estonia: programme and abstract book: 79-79, 2016
42Saar S., Sokirjanski M., Junkin LK., Laos J., Laar AL., Merioja I., Lepner U., Kukk L., Remmelgas A., Asser T., Innos K., Starkopf J., Talving P.
Evolution of severe trauma in Estonia comparing time segments of early versus established independence of the state
European Journal of Trauma and Emergency Surgery: 42 (2, Suppl), S94-S95, 2016
43Schneider S., Kornejeva A., Vibo R., Kõrv J.
Stroke severity among young ischemic stroke patients in Estonia
European Stroke Journal: 1 (1 Suppl), 378, 2016
44Soosaar I., Saar S., Lomp A., Laos J., Laht M., Mihnovitš V., Šalkauskas R., Väli M., Lustenberger T., Lepner U., Kukk L., Starkopf J., Talving P.
Population–based investigation of traumatic vascular injuries in Estonia: 353 consecutive cases
European Journal of Trauma and Emergency Surgery: 42 (2, Suppl), S25-S26, 2016
45Škorvanek M., Martinez-Martin P., Kovacs N., Zezula I., Rodriguez-Violante M., Corvol JC., Taba P., Seppi K., Levin O., Schrag A., Foltynie T., Alvarez-Sanchez M., Arakaki T., Aschermann Z., Aviles-Olmos I., Benchetrit E., Benoit C., Bergareche-Yarza A., Cervantes-Arriaga A., Chade A., Cormier F., Datieva V., Gallagher DA., Garretto N., Gdovinova Z., Gershanik O., Grofik M., Han V., Huang J., Kadastik-Eerme L., Kurtis MM., Mangone G., Martinez-Castrillo JC., Mendoza-Rodriguez A., Minar M., Moore HP., Muldmaa M., Mueller C., Pinter B., Poewe W., Rallmann K., Reiter E., Rodriguez-Blazquez C., Singer C., Tilley BC., Valkovic P., Goetz CG., Stebbins GT.
Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)
Movement Disorders: 31 (Suppl 2), S513-S513, 2016
46Škorvanek M., Martinez-Martin P., Kovacs N., Zezula I., Rodriguez-Violante M., Corvol JC., Taba P., Seppi K., Levin O., Schrag A., Foltynie T., Alvarez-Sanchez M., Arakaki T., Aschermann Z., Aviles-Olmos I., Benchetrit E., Benoit C., Bergareche-Yarza A., Cervantes-Arriaga A., Chade A., Cormier F., Datieva V., Gallagher DA., Garretto N., Gdovinova Z., Gershanik O., Grofik M., Han V., Huang J., Kadastik-Eerme L., Kurtis MM., Mangone G., Martinez-Castrillo JC., Mendoza-Rodriguez A., Minar M., Moore HP., Muldmaa M., Mueller C., Pinter B., Poewe W., Rallmann K., Reiter E., Rodriguez-Blazquez C., Singer C., Tilley BC., Valkovic P., Goetz CG., Stebbins GT.
Relationship between the MDS-UPDRS and quality of life in Parkinson's disease: A large international multicenter study of 3206 patients (the QUALPD study)
Movement Disorders: 31 (Suppl 2), S163-S163, 2016
47Zemtsovskaja G., Borissova J., Palk K., Sorro U., Gross-Paju K., Brjalin V., Zemtsovski M., Nõukas K., Eino K., Tammeväli K., Pille V., Rebane K., Lepik K., Luman M., Viigimaa M.
The importance of front-line tests in diagnosis of porphyrias: 12 years of experience in North Estonia Medical Centre
Clinical Chemistry and Laboratory Medicine: 54 (10), eA355-eA355, 2016
48Zemtsovskaja G., Pikta M., Borissova J., Palk K., Sorro U., Gross-Paju K., Brjalin V., Zemtsovski M., Nõukas K., Eino K., Tammeväli K., Pille V., Lotkova O., Lepik K., Luman M., Viigimaa M.
Brain-to-brain loop concept in application to porphyrias: 10-year experience at North Estonia Medical Centre
Eesti Arst: 95 (Lisa 1), 61-61, 2016
49Zemtsovskaja G., Pikta M., Borissova J., Palk K., Sorro U., Gross-Paju K., Brjalin V., Zemtsovski M., Nõukas K., Eino K., Tammeväli K., Pille V., Lotkova O., Lepik K., Luman M., Viigimaa M.
Investigation of porphyrias: 10-year experience at the North Estonia Medical Centre
Eesti Arst: 95 (Lisa 1), 61-61, 2016
50Zemtsovskaja G., Zemtsovski M., Luman M., Viigimaa M.
Lipid profile in a patient with familial hyperlipidemia during 18 years of treatment
Clinical Chemistry and Laboratory Medicine: 54 (10), eA284-eA284, 2016
51Zirel K., Gaidajenko A., Šatalov U., Volovik V., Popov A.
The features of first aid and health care providing on Estonian small islands
Clinical Health Promotion: 6 (Suppl 1), 98-99, 2016
52Zordania R., Põder H., Uritam M., Rebane I., Lepik K., Joost K.
Hemihüperplaasia - embrüonaalsete kasvajate oluline riskifaktor
Eesti Lastearstide Seltsi XXI kongress 2.–4. juuni 2016, Tallinn: 38-38, 2016
53Tamm M., Oselin K., Kivistik PA., Kals M., Keerma K., Roosipuu R., Leismann T., Roomere H., Metspalu A., Tõnisson N.
Detecting Cancer Related Mutations in Cell-Free DNA of Lung Cancer Patients
Human Heredity: 81 (4), 227-227, 2016
54Tamm M., Oselin K., Kivistik PA., Keerma K., Roosipuu R., Saare M., Roomere H., Metspalu A., Tõnisson N.
Detecting EGFR and related mutations in the cfDNA of lung cancer patients
European Journal of Human Genetics: 24 (E-Suppl 1), 313-313, 2016
55Teeäär T., Serg M., Kals J., Zilmer M., Eha J., Kampus P.
Südame löögisageduse mõju tsentraalsele hemodünaamikale
Eesti Arst: 95 (Lisa 2), 29-29, 2016
56Tilk M., Kuusmets E., Lellep A.
Application of six sigma for quality assurance at the laboratory of North EstoniaMedical Centre
Eesti Arst: 95 (Lisa 1), 62-62, 2016
57Toft N., Birgens H., Abrahamsson J., Griškevičius L., Hallböök H., Heyman M., Klausen TW., Jonsson OG., Palk K., Pruunsild K., Quist-Paulsen P., Vaitkevičiene GE., Vettenranta K., Asberg A., Frandsen TL., Marquart HV., Madsen HO., Noren-Nyström U., Schmiegelow K.
Adults and Children (1-45 Years) with Ph-Negative All Have Almost Identical Outcome in Risk-Stratified Analysis of Nopho All2008
Haematologica: 101 (Suppl 1), 35-35, 2016
58Tomberg K.
Syndrome based test panels in hospital laboratory
Eesti Arst: 95 (Lisa 1), 32-32, 2016
59Tomson R., Fridolin I., Luman M., Holmar J.
The effect of Kt/V on post dialysis urea rebound in hemodialysis and hemodiafiltration
Nephrology Dialysis Transplantation: 31 (Suppl 1), 1490-1490, 2016
60Vaht M., Kurrikoff T., Laas K., Veidebaum T., Harro J.
Effects of oxytocin receptor gene polymorphism (rs53576) on alcohol use in a longitudinal population representative study
European Neuropsychopharmacology: 26 (Suppl 2), S671-S671, 2016
61Valk E., Jõeste E., Saranova D., Kukk L., Vilbiks KL.
Prostate HistoScanning™ system has no benefits compared to the standard 12-core TRUS-guided biopsy and is often unreliable
European Urology Supplements: 15 (5), Tees nr e1178, 2016
62Vettus E., Kurvits K., Oselin K.
Comparison of the usage of granulocyte colony-stimulating factors (G-CSF) in the Baltic and Nordic countries in 2011-2014
Annals of Oncology: 27 (Suppl 6), Tees nr 1476P, 2016
63Vibo R., Tomberg T., Kampus P., Salum E., Ennok M., Kõrv J.
Magnetic resonance spectroscopy in healthy subjects with incidental brain white matter lesions
European Stroke Journal: 1 (1 Suppl), 242, 2016
64Vrdoljak E., Elme A., Kusic Z., Park JO., Udrea AA., Kim SY., Ahn JB., Villalobos R., Srinivasan K., Bilic A., Manojlovic N., Dong J., Guan XS., Lofton-Day C., Jung AS., Kim TW.
Association of ECOG performance status with efficacy in patients receiving panitumumab with best supportive care (BSC) vs BSC alone for chemorefractory metastatic colorectal cancer
Journal of Clinical Oncology: 34 (15, Suppl S), Tees nr e15018, 2016
Muud publikatsioonid
1Anton L.
Diureetikumide kasutamine ambulatoorses ravis
Perearst: 1 (110), 45-48, 2016
2Gabovitš B., Karjagin J., Laisaar KT., Sillaste P., Paliale M., Rebo M., Ilmoja ML., Laidmäe E., Valk H., Szirko G., Kagalo S., Palmiste-Kallion V., Ussova S., Pakkonen K., Treiman-Kiveste A., Lass J., Härma E., Riigor KM., Pool K., Avarsoo M., Raid U.
Perioperatiivne ägeda valu käsitlus
Perioperatiivne ägeda valu käsitlus: 82, 2016
3Hade J.
Naha ja pehmete kudede infektsioonid nõuavad kiiret ravi
Apteeker: 7 (91), 11-13, 2016
4Joller K.
Esmaabikomplekt komplekteeri kasutajate järgi
Apteeker: 5 (89), 12-14, 2016
5Joller K.
Külmetushaiguste ravi krooniliste haigustega patsientidel
Apteeker: 2 (86), 7-9, 2016
6Joller K.
Lisatoit beebi menüüs
Perearst: 8 (117), 21-23, 2016
7Joller K.
Mida soovitada seljavaluga patsiendile?
Apteeker: 3 (87), 17-19, 2016
8Joller K.
Ülemiste hingamisteede ägedad viirusinfektsioonid
Apteeker: 6 (90), 40-42, 2016
9Jussi A.
Tinnitus – ravida või leppida?
Perearst: 3 (112), 53-53, 2016
10Jürisson M.
Atoopiline dermatiit haigusjuhu näitel
Perearst: 11 (120), 31-34, 2016
11Kaha T.
Haavaravist pereõele
Pereõde: 2 (19), 14-15, 2016
12Kaha T.
Probleemidest haavaravis
Apteeker: 2 (86), 33-35, 2016
13Kalling K., Arefjeva K., Kompus M., Evomaa I., Pärtel M.
Beniigsed häälehäired
Perearst: 4 (113), 72-75, 2016
14Kaur I., Janvest K., Raid U., Oder M.
Bariaatriliseks operatsiooniks valmistumine ja elu pärast operatsiooni
Bariaatriliseks operatsiooniks valmistumine ja elu pärast operatsiooni: 30, 2016
15Keldo E.
Õdede töökoormus
Eesti Õde: 2, 2016
16Laheäär M.
Milleks tromboosikabinet?
Perearst: 6 (115), 31--31, 2016
17Laheäär M.
Perifeersete arterite haigus sisearsti pilgu läbi
Perearst: 7 (116), 21-23, 2016
18Lepp HL.
Alatoitumus ja kliiniline toitmine
Perearst: 5 (114), 57-59, 2016
19Lepp HL.
Toiduga seotud soovimatud reaktsioonid: seedeprobleemid ning toidutalumatus
Pereõde: 2 (19), 23-25, 2016
20Luik M., Kärner A., Puusepp K., Sepp A.
SA Põhja-Eesti Regionaalhaiglas töötavate õdede valmisolek taaselustamiseks
Eesti Õde: 1, 20-23, 2016
21Meresmaa K., Urbala M., Matso K., Saar M.
Ravimite valmistamine haiglaapteegis – täna ja homme
Apteeker: 2 (86), 36-37, 2016
22Miller E.
Sinusiit ja otiit
Perearst: 7 (116), 38-41, 2016
23Mitt T.
Diabeedi diagnoosimine ja glükeemilised eesmärgid
Perearst: 3 (112), 15-18, 2016
24Põldveer M.
Läbipõlemise seosed
Eesti Õde: 3, 11-14, 2016
25Rõigas M., Vaher H.
Adenoidi ja mandlitega seotud haigused lapseeas
Perearst: 10 (119), 67-71, 2016
26Sõõru E.
Pereõed osalevad üha rohkem unetervise parandamisel
Pereõde: 3 (20), 15-17, 2016
27Sõõru E.
Uneapnoe – mitte üksnes kaelaümbermõõdust sõltuv unehäire
Apteeker: 3 (87), 26-29, 2016
28Sõõru E., Vaher H., Hion T., Veldi M., Siilak T., Jagomägi T., Pirn P., Nigol H.
Uneapnoe sõidukijuhi tervisetõendi väljastamisel
Apteeker: 1 (110), 15-17, 2016
29Tuvik P.
Reaktiivne artriit
Perearst: 1 (110), 25-27, 2016
30Viigimaa M.
Hüpertensioon on enamat kui kõrge vererõhk: lipiiditaset langetavast ravist hüpertensioonipatsientidel
Perearst: 9 (118), 69-70, 2016
Ravijuhendid
1Ambos A., Raie E., Kiudma T., Reppo I., Rätsep A., Tammiksaar K., Toomsoo T., Volke V.
2. tüüpi diabeedi Eesti ravijuhend 2016
Eesti Arst: 95 (7), 465-473, 2016
2Gabovitš B., Karjagin J., Laisaar KT., Sillaste P., Paliale M., Rebo M., Ilmoja ML., Laidmäe E., Valk H., Szirko G., Kagalo S., Palmiste-Kallion V., Ussova S., Pakkonen K., Treiman-Kiveste A., Lass J., Härma E., Riigor KM., Pool K., Avarsoo M., Raid U.
Perioperatiivne ägeda valu käsitlus
Perioperatiivne ägeda valu käsitlus: 82, 2016